Letrozole treatment for women with PCOS
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how well the medicine letrozole helps women with polycystic ovary syndrome (PCOS) ovulate. It checks if certain lab and ultrasound findings predict how well someone responds to the treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 40 years old.
- You have been diagnosed with PCOS using the Rotterdam criteria.
- You have not taken letrozole before to induce ovulation.
- You are willing to follow the treatment plan and come to follow-up visits.
- Your infertility is not due to blocked fallopian tubes or male factor issues.
- You have not had ovarian surgery or taken medications that affect ovulation recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a low-dose thyroid hormone (levothyroxine) to the standard fertility treatment letrozole improves pregnancy rates in women with both PCOS and mild hypothyroidism. It may help if you have trouble getting pregnant and have these two conditions.
This trial tests adding quercetin or alpha lipoic acid to standard PCOS care to see if they improve symptoms and blood markers. It may help women who have irregular periods or signs of excess androgens like acne.
This study compares two methods (HOMA1-IR and HOMA2-IR) of measuring insulin resistance to see which one better predicts whether women with PCOS will ovulate after treatment. It aims to find a simple blood test that could help guide fertility treatment.
This trial tests a longer course of letrozole to help women with PCOS ovulate and get pregnant. The goal is to see if extended therapy works better than the standard treatment.
This study tests if adding cabergoline to letrozole works better than letrozole alone to help women with PCOS ovulate. It may help participants who have not had success with standard treatments.
This study tests whether letrozole, a hormone-blocking medicine, can help people with newly diagnosed low-grade serous ovarian cancer that has hormone receptor proteins (ER and/or PgR) after surgery. It compares outcomes to see if blocking estrogen can slow the cancer’s return or progression.
Hear when a new PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.